I Don’t Know About You, But I’m Feeling These 22 Biotech Stocks
The market is in a transitional phase as we await earnings.
The market is in a transitional phase as we await earnings.
I’m heavily weighted in this one sector, while adding to one name on news.
Here’s how I’m playing a solid reaction to the Iran deal but no euphoria.
A $23 million move by the small-cap concern has me looking to increase my position.
Here’s my strategy as the Dow rises as cash rotates out of overbought semiconductor stocks.
I’m upping the defense as I don’t like what I see.